カテゴリ： 世界, 医療/バイオ, Market Monitor Global

眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント

■ 英語タイトル：Sustained Release Ocular Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8692）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8692
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：77
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥487,500見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥633,750見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥731,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の眼科用徐放性ドラッグデリバリーシステム市場規模と予測を収録しています。・世界の眼科用徐放性ドラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年
・世界の眼科用徐放性ドラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の眼科用徐放性ドラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソーム」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

眼科用徐放性ドラッグデリバリーシステムのグローバル主要企業は、pSivida、 Allergan、 Icon Bioscience、 Ocular Therapeutix、 Neurotech Pharmaceuticals、 Santen Pharmaceutical、 Aciont Inc.、 Envisia Therapeutics、 GrayBug、 Innocore Pharmaceuticals、 OHR Pharmaceuticals、 PolyActiva、 TheraKineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、眼科用徐放性ドラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の眼科用徐放性ドラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年
世界の眼科用徐放性ドラッグデリバリーシステム市場：タイプ別市場シェア、2022年
・リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント

世界の眼科用徐放性ドラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年
世界の眼科用徐放性ドラッグデリバリーシステム市場：用途別市場シェア、2022年
・白内障、緑内障、角膜移植、その他

世界の眼科用徐放性ドラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年
世界の眼科用徐放性ドラッグデリバリーシステム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における眼科用徐放性ドラッグデリバリーシステムのグローバル売上、2018年-2023年
・主要企業における眼科用徐放性ドラッグデリバリーシステムのグローバル売上シェア、2022年
・主要企業における眼科用徐放性ドラッグデリバリーシステムのグローバル販売量、2018年-2023年
・主要企業における眼科用徐放性ドラッグデリバリーシステムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
pSivida、 Allergan、 Icon Bioscience、 Ocular Therapeutix、 Neurotech Pharmaceuticals、 Santen Pharmaceutical、 Aciont Inc.、 Envisia Therapeutics、 GrayBug、 Innocore Pharmaceuticals、 OHR Pharmaceuticals、 PolyActiva、 TheraKine

*************************************************************

・調査・分析レポートの概要
眼科用徐放性ドラッグデリバリーシステム市場の定義
市場セグメント
世界の眼科用徐放性ドラッグデリバリーシステム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の眼科用徐放性ドラッグデリバリーシステム市場規模
世界の眼科用徐放性ドラッグデリバリーシステム市場規模：2022年 VS 2029年
世界の眼科用徐放性ドラッグデリバリーシステム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの眼科用徐放性ドラッグデリバリーシステムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の眼科用徐放性ドラッグデリバリーシステム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント
眼科用徐放性ドラッグデリバリーシステムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：白内障、緑内障、角膜移植、その他
眼科用徐放性ドラッグデリバリーシステムの用途別グローバル売上・予測

・地域別市場分析
地域別眼科用徐放性ドラッグデリバリーシステム市場規模 2022年と2029年
地域別眼科用徐放性ドラッグデリバリーシステム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
pSivida、 Allergan、 Icon Bioscience、 Ocular Therapeutix、 Neurotech Pharmaceuticals、 Santen Pharmaceutical、 Aciont Inc.、 Envisia Therapeutics、 GrayBug、 Innocore Pharmaceuticals、 OHR Pharmaceuticals、 PolyActiva、 TheraKine
...

This report aims to provide a comprehensive presentation of the global market for Sustained Release Ocular Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sustained Release Ocular Drug Delivery Systems. This report contains market size and forecasts of Sustained Release Ocular Drug Delivery Systems in global, including the following market information:
Global Sustained Release Ocular Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Sustained Release Ocular Drug Delivery Systems Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Sustained Release Ocular Drug Delivery Systems companies in 2022 (%)
The global Sustained Release Ocular Drug Delivery Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Liposome Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sustained Release Ocular Drug Delivery Systems include pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics and GrayBug, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sustained Release Ocular Drug Delivery Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sustained Release Ocular Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
Global Sustained Release Ocular Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
Cataract
Glaucoma
Corneal Transplantation
Others
Global Sustained Release Ocular Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Sustained Release Ocular Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sustained Release Ocular Drug Delivery Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sustained Release Ocular Drug Delivery Systems revenues share in global market, 2022 (%)
Key companies Sustained Release Ocular Drug Delivery Systems sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Sustained Release Ocular Drug Delivery Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sustained Release Ocular Drug Delivery Systems, market overview.
Chapter 2: Global Sustained Release Ocular Drug Delivery Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Sustained Release Ocular Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sustained Release Ocular Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sustained Release Ocular Drug Delivery Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Sustained Release Ocular Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sustained Release Ocular Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sustained Release Ocular Drug Delivery Systems Overall Market Size
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size: 2022 VS 2029
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Sustained Release Ocular Drug Delivery Systems Sales: 2018-2029
3 Company Landscape
3.1 Top Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.2 Top Global Sustained Release Ocular Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Companies
3.4 Global Sustained Release Ocular Drug Delivery Systems Sales by Companies
3.5 Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sustained Release Ocular Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Players in Global Market
3.8.1 List of Global Tier 1 Sustained Release Ocular Drug Delivery Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Sustained Release Ocular Drug Delivery Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Sustained Release Ocular Drug Delivery Systems Market Size Markets, 2022 & 2029
4.1.2 Liposome
4.1.3 Microcapsules/Nanocapsules
4.1.4 Microspheres/Nanosptheres
4.1.5 Implants
4.2 By Type – Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2029
4.2.3 By Type – Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2029
4.3 By Type – Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
4.3.1 By Type – Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
4.3.2 By Type – Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2029
4.3.3 By Type – Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2029
4.4 By Type – Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sustained Release Ocular Drug Delivery Systems Market Size, 2022 & 2029
5.1.2 Cataract
5.1.3 Glaucoma
5.1.4 Corneal Transplantation
5.1.5 Others
5.2 By Application – Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2029
5.2.3 By Application – Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2029
5.3 By Application – Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
5.3.1 By Application – Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
5.3.2 By Application – Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2029
5.3.3 By Application – Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2029
5.4 By Application – Global Sustained Release Ocular Drug Delivery Systems Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Sustained Release Ocular Drug Delivery Systems Market Size, 2022 & 2029
6.2 By Region – Global Sustained Release Ocular Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region – Global Sustained Release Ocular Drug Delivery Systems Revenue, 2024-2029
6.2.3 By Region – Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share, 2018-2029
6.3 By Region – Global Sustained Release Ocular Drug Delivery Systems Sales & Forecasts
6.3.1 By Region – Global Sustained Release Ocular Drug Delivery Systems Sales, 2018-2023
6.3.2 By Region – Global Sustained Release Ocular Drug Delivery Systems Sales, 2024-2029
6.3.3 By Region – Global Sustained Release Ocular Drug Delivery Systems Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2029
6.4.2 By Country – North America Sustained Release Ocular Drug Delivery Systems Sales, 2018-2029
6.4.3 US Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.4.4 Canada Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.4.5 Mexico Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2029
6.5.2 By Country – Europe Sustained Release Ocular Drug Delivery Systems Sales, 2018-2029
6.5.3 Germany Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.4 France Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.5 U.K. Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.6 Italy Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.7 Russia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.8 Nordic Countries Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.5.9 Benelux Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2029
6.6.2 By Region – Asia Sustained Release Ocular Drug Delivery Systems Sales, 2018-2029
6.6.3 China Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.6.4 Japan Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.6.5 South Korea Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.6.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.6.7 India Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2029
6.7.2 By Country – South America Sustained Release Ocular Drug Delivery Systems Sales, 2018-2029
6.7.3 Brazil Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.7.4 Argentina Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Sustained Release Ocular Drug Delivery Systems Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales, 2018-2029
6.8.3 Turkey Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.8.4 Israel Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.8.5 Saudi Arabia Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
6.8.6 UAE Sustained Release Ocular Drug Delivery Systems Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 pSivida
7.1.1 pSivida Company Summary
7.1.2 pSivida Business Overview
7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.1.5 pSivida Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Icon Bioscience
7.3.1 Icon Bioscience Company Summary
7.3.2 Icon Bioscience Business Overview
7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.3.5 Icon Bioscience Key News & Latest Developments
7.4 Ocular Therapeutix
7.4.1 Ocular Therapeutix Company Summary
7.4.2 Ocular Therapeutix Business Overview
7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.4.5 Ocular Therapeutix Key News & Latest Developments
7.5 Neurotech Pharmaceuticals
7.5.1 Neurotech Pharmaceuticals Company Summary
7.5.2 Neurotech Pharmaceuticals Business Overview
7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.5.5 Neurotech Pharmaceuticals Key News & Latest Developments
7.6 Santen Pharmaceutical
7.6.1 Santen Pharmaceutical Company Summary
7.6.2 Santen Pharmaceutical Business Overview
7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.6.5 Santen Pharmaceutical Key News & Latest Developments
7.7 Aciont Inc.
7.7.1 Aciont Inc. Company Summary
7.7.2 Aciont Inc. Business Overview
7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.7.5 Aciont Inc. Key News & Latest Developments
7.8 Envisia Therapeutics
7.8.1 Envisia Therapeutics Company Summary
7.8.2 Envisia Therapeutics Business Overview
7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.8.5 Envisia Therapeutics Key News & Latest Developments
7.9 GrayBug
7.9.1 GrayBug Company Summary
7.9.2 GrayBug Business Overview
7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.9.5 GrayBug Key News & Latest Developments
7.10 Innocore Pharmaceuticals
7.10.1 Innocore Pharmaceuticals Company Summary
7.10.2 Innocore Pharmaceuticals Business Overview
7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.10.5 Innocore Pharmaceuticals Key News & Latest Developments
7.11 OHR Pharmaceuticals
7.11.1 OHR Pharmaceuticals Company Summary
7.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Business Overview
7.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.11.5 OHR Pharmaceuticals Key News & Latest Developments
7.12 PolyActiva
7.12.1 PolyActiva Company Summary
7.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Business Overview
7.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.12.5 PolyActiva Key News & Latest Developments
7.13 TheraKine
7.13.1 TheraKine Company Summary
7.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Business Overview
7.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Major Product Offerings
7.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Sales and Revenue in Global (2018-2023)
7.13.5 TheraKine Key News & Latest Developments
8 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, Analysis
8.1 Global Sustained Release Ocular Drug Delivery Systems Production Capacity, 2018-2029
8.2 Sustained Release Ocular Drug Delivery Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Sustained Release Ocular Drug Delivery Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sustained Release Ocular Drug Delivery Systems Supply Chain Analysis
10.1 Sustained Release Ocular Drug Delivery Systems Industry Value Chain
10.2 Sustained Release Ocular Drug Delivery Systems Upstream Market
10.3 Sustained Release Ocular Drug Delivery Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sustained Release Ocular Drug Delivery Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • パーソナルケア用デリバリーシステムの世界市場2023年：リポソーム、マイクロカプセル化、その他
  • 球状砂糖のグローバル市場展望 2023年-2029年：マイクロスフィア、スタンダードスフィア
  • リポソーム開発サービスのグローバル市場展望 2023年-2029年：リポソーム、脂質ナノ粒子
  • 外反母趾補正装置のグローバル市場（2022年-2029年）：インプラント・付属品、ウェアラブル
  • 世界の補聴器・インプラント・診断市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8692 )"眼科用徐放性ドラッグデリバリーシステムのグローバル市場展望 2023年-2029年：リポソーム、マイクロカプセル/ナノカプセル、マイクロスフィア/ナノスフィア、インプラント" (英文：Sustained Release Ocular Drug Delivery Systems Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。